These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 23387899

  • 1. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S.
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [Abstract] [Full Text] [Related]

  • 2. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT.
    J Med Chem; 2011 Dec 22; 54(24):8271-7. PubMed ID: 22077347
    [Abstract] [Full Text] [Related]

  • 3. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT, Winum JY.
    Expert Opin Drug Discov; 2015 Jun 22; 10(6):591-7. PubMed ID: 25891195
    [Abstract] [Full Text] [Related]

  • 4. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A, Carta F, Ceruso M, Bartolucci G, Supuran CT.
    Bioorg Med Chem; 2015 Nov 01; 23(21):6955-66. PubMed ID: 26432607
    [Abstract] [Full Text] [Related]

  • 5. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
    Monti SM, Supuran CT, De Simone G.
    Expert Opin Ther Pat; 2013 Nov 01; 23(6):737-49. PubMed ID: 23672415
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 01; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 7. Novel sulfonamide compounds for inhibition of metastatic tumor growth (WO2012021963).
    Colinas PA.
    Expert Opin Ther Pat; 2013 Jan 01; 23(6):761-3. PubMed ID: 23566197
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT.
    Expert Opin Investig Drugs; 2018 Dec 01; 27(12):963-970. PubMed ID: 30426805
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
    Chandra KM, Goud NS, Arifuddin M, Alvala M, Alvala R, Angeli A, Supuran CT.
    Bioorg Med Chem Lett; 2021 May 01; 39():127877. PubMed ID: 33640442
    [Abstract] [Full Text] [Related]

  • 10. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX.
    Sharma A, Tiwari M, Supuran CT.
    J Enzyme Inhib Med Chem; 2014 Apr 01; 29(2):292-6. PubMed ID: 23488741
    [Abstract] [Full Text] [Related]

  • 11. Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII.
    Redij A, Carradori S, Petreni A, Supuran CT, Toraskar MP.
    Anticancer Agents Med Chem; 2023 Apr 01; 23(10):1217-1223. PubMed ID: 36825712
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT, Winum JY.
    Future Med Chem; 2015 Apr 01; 7(11):1407-14. PubMed ID: 26230880
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases.
    De Luca L, Mancuso F, Ferro S, Buemi MR, Angeli A, Del Prete S, Capasso C, Supuran CT, Gitto R.
    Eur J Med Chem; 2018 Jan 01; 143():276-282. PubMed ID: 29197732
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT.
    J Am Chem Soc; 2006 Jun 28; 128(25):8329-35. PubMed ID: 16787097
    [Abstract] [Full Text] [Related]

  • 15. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A, Dogné JM, Masereel B, Supuran CT.
    Trends Pharmacol Sci; 2006 Nov 28; 27(11):566-73. PubMed ID: 16996620
    [Abstract] [Full Text] [Related]

  • 16. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Carta F, Maresca A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2012 Apr 01; 20(7):2266-73. PubMed ID: 22377674
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G, Supuran CT.
    Biochim Biophys Acta; 2010 Feb 01; 1804(2):404-9. PubMed ID: 19679200
    [Abstract] [Full Text] [Related]

  • 18. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
    Grandane A, Tanc M, Zalubovskis R, Supuran CT.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1256-60. PubMed ID: 24518190
    [Abstract] [Full Text] [Related]

  • 19. Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer.
    Winum JY, Colinas PA, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1419-26. PubMed ID: 23199483
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
    Winum JY, Rami M, Scozzafava A, Montero JL, Supuran C.
    Med Res Rev; 2008 May 15; 28(3):445-63. PubMed ID: 17880011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.